Sept 15 (Reuters) - The attorney general of New York filed a lawsuit against Actavis Plc and its subsidiary to stop the companies from discontinuing its Alzheimer's drug, alleging that they were trying to maintain a monopoly position illegally.
Eric Schneiderman, New York's attorney general, alleges that Actavis and its subsidiary Forest Laboratories violated anti-trust and state laws.
05:35 Arkansas carries out first execution since 2005 after Supreme Court denies stay requests19
05:18 The Latest: Inmate lost consciousness quickly, witnesses say24
05:18 Arkansas Puts Ledell Lee to Death, in Its First Execution Since 200525
01:38 Arkansas courts stay execution, block state from using lethal injection drug35